Revolutionizing outpatient LESS™ technologies to treat back pain .
Purpose
Welcome to NANISX where our purpose is to create, acquire, incubate, and bring to market patented, unique, and essential inventions through our proprietary LESS™ Exposure Advanced Spine Technologies (LEAST™) to propel the movement of spine surgery from hospitals to outpatient centers worldwide.
A Growing Problem
The low back pain market, with 619 million affected in 2020 and expected to rise to 843 million by 2050 due to aging, presents a significant investment opportunity. The increasing prevalence highlights the urgent need for innovative treatments in this expanding sector.
Key Solutions
Focus Areas
We are deeply committed to identifying and nurturing revolutionary innovations that could be the best in class solutions for advancing outpatient spine surgery globally
Synthetic Osteobiologics
Interspinous Fixation
Sacroiliac Joint
Fixation
Transfacet
Fixation
Track Record
19000+
DEVICES IMPLANTED
25+
GLOBAL PATENTS
7+
US FDA CLEARED DEVICES
$49M+
PRODUCT REVENUES
20+
RESEARCH PAPERS
10+
Countries Utilize NANISX
Training
NANISX is right for your patients !!
Enroll for your personalized training lab.